YI Jia, HOU Xingyun, HUANG Lifeng, CHEN Wansheng. Practice and experience in the participant of the clinical pharmacist in the treatment of cancer pain with renal insufficiency[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(5): 474-477. doi: 10.3969/j.issn.1006-0111.2016.05.024
Citation:
|
YI Jia, HOU Xingyun, HUANG Lifeng, CHEN Wansheng. Practice and experience in the participant of the clinical pharmacist in the treatment of cancer pain with renal insufficiency[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(5): 474-477. doi: 10.3969/j.issn.1006-0111.2016.05.024
|
Practice and experience in the participant of the clinical pharmacist in the treatment of cancer pain with renal insufficiency
-
Department of Pharmacy, Changzheng Hospital Affiliated to Second Military Medical University, Shanghai 200003, China
- Received Date: 2015-08-26
- Rev Recd Date:
2016-03-18
-
Abstract
Objective To investigate the effect of clinical pharmacists in the analgesic therapysoas to improve the rational use of analgesic drugs. Methods Clinical pharmacists participated in the formulation of drug therapy plan for the patient of cancer pain with renal insufficiency in respects of drug selection, dosage and adverse reaction monitoring. Results Physicians accepted suggestions from clinical pharmacists.The first day, the morphine hydrochloride tablets were used for rapid titration. The next day doxycodone were used, adding the morphine hydrochloride tablets when required. After the pain was controlled stability, the transdermal fentanyl was used to alleviate the damage of kidney. Conclusion The clinical pharmacist could assist clinicians to adjust the therapeutic regimen of the cancer patients with severe pain and improve the level of clinical drug treatment.
-
References
[1]
|
李小梅,董艳娟,李慧莉,等. 阿片耐受与慢性癌痛的阿片类药物治疗[J]. 中国疼痛医学杂志,2012,18(9):561-565. |
[2]
|
Dhingra L, Lam K,Homel P,et al. Pain in underserved community-dwelling Chinese American cancer patients: demographic andmedical correlates[J].Oncologist,2011,16(4):523-533. |
[3]
|
刘 芳,付 平. 恶性肿瘤肾损害[J]. 中国实用内科杂志,2011,31(2):100-101. |
[4]
|
王雅琦,王美鉴,邱志敏,等. 芬太尼透皮贴在肾功能不全的癌痛患者中的应用[J].实用癌症杂志,2012,27(5):529-530. |
[5]
|
Boger RH. Renal impairment: a challenge for opioid treatment? The role of buprenorphine[J].Palliat Med, 2006,20(1):17-23. |
[6]
|
任玉娥,段红光,倪家骧. 芬太尼缓释透皮贴剂的临床药理学[J]. 中国疼痛医学杂志, 2002, 8(3):169-172. |
[7]
|
程 熠,于世英. 阿片类药物在肝肾功能不全癌痛患者中的选择应用[J].中国肿瘤,2011,20(4):278-282. |
[8]
|
周晓敏. 盐酸羟考酮控释片治疗癌痛的研究进展[J].广西医科大学学报,2009,26(5):813-815. |
[9]
|
Meeker MA,Finnell D, Othman AK. Family caregivers and cancer pain management: a review[J]. J Fam Nurs, 2011,17(1):29-60. |
-
-
Proportional views
-